Novo Nordisk
Kasim Kutay is a Member of the Board at Novo Nordisk. Kasim has previously worked as Gimv, CW+ Chelsea and Westminster Hospital NHS Foundation Trust, ConvaTec, Novo Nordisk, Novozymes, Novo Holdings, and Moelis & Company.
Kutay has a long history of working in finance and investments. Kasim started their career at Moelis & Company in 2009 as a partner and co-head of Europe. Kasim was with the company for seven years before leaving in 2016 to join NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH as a trustee.
Kutay has also been involved with SOAS University of London as a member of the investment committee overseeing the university endowment.
Kasim Kutay has a MSc and a BSc in Economics from The London School of Economics and Political Science (LSE).
This person is not in the org chart
This person is not in any teams
Novo Nordisk
380 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.